SafeAlleleSCA, a pioneering precision gene therapy project for Machado–Joseph disease, has been awarded the €100,000 Jorge Ruas Award at the Final Event of the Tecnimede Open Innovation Competition 2026, held on 27 May at the Pavilhão do Conhecimento in Lisbon.
Final Event to showcase breakthrough pharmaceutical technologies in Lisbon
The Tecnimede Open Innovation Competition is entering its final stage, bringing together international experts, researchers, startups, investors, and pharmaceutical innovation stakeholders for the 2026 Final Event.
The Final Event will take place on 27 May, from 14:00 to 18:10, at the Pavilhão do Conhecimento.
10 Finalists selected to compete for the Jorge Ruas Award
The Tecnimede Open Innovation Competition has reached its final stage, with 10 finalist teams selected to compete for the Jorge Ruas Award at the Final Event.
Applications Closed – Evaluation Phase Begins
The application period for the Tecnimede Open Innovation Competition 2026 is now officially closed, marking the start of the next phase in identifying breakthrough innovations in pharmaceutical technologies. We would like to thank all the individuals, research groups, startups, and established…
Applying to the Tecnimede Open Innovation Competition 2026? Join one of our four online info sessions taking place on 8 January, 28 January, 19 February or 4 March at 11:00 GMT.
Have questions? We will host four online Info Sessions Are you considering applying to the Tecnimede Open Innovation Competition 2026 and would like to better understand its scope, requirements, and evaluation process? To support potential applicants, we will host four online Info Sessions, designed to…
Applications are open for the Tecnimede Open Innovation Competition! Win the €100k Jorge Ruas Award and unlock potential collaboration opportunities with Tecnimede Group to shape the future of pharmaceutical technologies.
Applications are open for the Tecnimede Open Innovation Competition, an initiative from the Tecnimede Group developed in collaboration with HiSeedTech, to identify and support breakthrough innovations in pharmaceutical technologies. The Competition aims to recognise and support transformative solutions in Pharmaceutical Technology,…
Aila Biotech Wins the First Jorge Ruas Award of the Tecnimede Open Innovation Competition
The first edition of the Jorge Ruas Award for Innovation in Pharmaceutical Technology concluded with a celebration of cutting-edge science and collaboration between academia and industry. The ceremony took place at the Portuguese Pharmaceutical Society, in Lisbon, as part of the…
Meet the 10 Finalists Competing for the Jorge Ruas Award
The Tecnimede Open Innovation Competition aims to foster collaboration between Tecnimede Group and innovators in the field of pharmaceutical technologies, including academic scientists, startups, and biopharmaceutical companies. Launched in collaboration with HiSeedTech, the competition attracted a highly competitive pool of applications…
Join the Pharma Revolution: Tecnimede Open Innovation Competition at the 2025 EAFP Annual Conference
We are excited to announce that the Tecnimede Open Innovation Competition will be present at the 2025 EAFP Annual Conference, taking place from May 13th to 15th in Coimbra, Portugal. As a global initiative focused on advancing innovation in pharmaceutical technology, our participation in this premier European…
5 Days Left to apply to the Tecnimede Open Innovation Competition: €100K + Tecnimede Partnership Awaits Your pharmaceutical technology innovation!
The Tecnimede Open Innovation Competition is closing soon. Don’t miss this final opportunity to: We’re focused on projects in: (and welcome innovative projects in related fields like drug development, formulation, and anotechnology!) Worth the Effort: We know applying takes time, but the…